// App-Quantinova.ai

SAT0099 : BMI AND TREATMENT SURVIVAL IN RA PATIENTS STARTING TREATMENT WITH TNFΑ-INHIBITORS: LONG TERM FOLLOW-UP IN THE REAL LIFE METEOR REGISTRY

Researchers

Presenter

  • S. A. Bergstra

Principal Investigators

  • D. Vega-Morales

  • E. Murphy

  • M. De Buck

  • K. Solomon-Escoto

  • T. Huizinga

  • C. Allaart

Medical Centers

  • LUMC, Radiology, Leiden, Netherlands

  • Universidad Autónoma de Nuevo León, Rheumatology, Monterrey, Mexico

  • University Hospital Wishaw, Wishaw, United Kingdom

  • Haaglanden Medical Center, The Hague, Netherlands

  • University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, United States

Locations

  • Netherlands

  • Mexico

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Obesity

Biomarkers

  • Body mass index

Drug/Treatment

  • Glucocorticoid

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Ablynx

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved